Based on the clinical evidence and the patient profiles where the compound appears most applicable, the following characteristics tend to describe good candidates for AOD 9604 evaluation when it is medically supervised: Patients with stubborn localized fat deposits that have not responded to diet and exercise, particularly visceral and lower abdominal fat Patients who cannot tolerate GLP-1 medications due to nausea, gastrointestinal side effects, or contraindications Active patients with reasonable baseline metabolic health who want a targeted lipolytic tool to complement their training and nutrition program Patients already on a peptide protocol who want to add a fat-targeting element to a GHK-Cu, NAD+, or sermorelin stack Patients who are not candidates for stimulant-based fat loss medications due to cardiovascular sensitivity, anxiety, or blood pressure concerns AOD 9604 is not appropriate as a standalone weight loss strategy for patients with significant obesity, insulin resistance, or metabolic syndrome
Core | 4-Week Supply PTD-DBM x 1 Duo x 1 Advanced | 4-Week Supply PTD-DBM x 1 Duo x 1 BPC Rapid Pro x 1 NMN x 1 HRT SUPPORT Hormone Support & Detoxification* HRT SUPPORT HRT SUPPORT+ Supports Sex Hormone Metabolism Through Phase 1 Detoxification Supports Immune Function & Immune Cell Activation Supports Strong Bones, Calcium Absorption & Metabolism Supports Cardiovascular Function Supports Neurological Function & Methylation Optimization Diindolylmethane Defend / Defend Pro Activated Magnesium Methylated B-Complex Omega 5X Take 1 packet daily, with a meal, or as directed by your healthcare practitioner
Some of the more common peptide therapies There are many different types of peptide therapies on the market today
Oxidized/unmodified-polyethylene microplastics neurotoxicity in mice: Perspective from microbiota-gut-brain axis
Presentacin: Vial x 7ml
